D-dimer, BNP/NT-pro-BNP, and creatinine are reliable decision-making biomarkers in life-sustaining therapies withholding and withdrawing during COVID-19 outbreak

D-dimer, BNP/NT-pro-BNP, and creatinine are reliable decision-making biomarkers in life-sustaining therapies withholding and withdrawing during COVID-19 outbreak

BackgroundThe decision for withholding and withdrawing of life-sustaining treatments (LSTs) in COVID-19 patients is currently based on a collegial and mainly clinical assessment. In the context of a global pandemic and overwhelmed health system, the question of LST decision support for COVID-19 pati...

Full description

Bibliographic Details
Main Authors: David M. Smadja, Benjamin A. Fellous, Guillaume Bonnet, Caroline Hauw-Berlemont, Willy Sutter, Agathe Beauvais, Charles Fauvel, Aurélien Philippe, Orianne Weizman, Delphine Mika, Philippe Juvin, Victor Waldmann, Jean-Luc Diehl, Ariel Cohen, Richard Chocron
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
COVID-19
life-sustaining therapies
withholding or withdrawing
ethics
claeys-léonetti law
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.935333/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.935333/full

Similar Items